Researchers discover a new non-opioid target to treat neuropathic pain
Researchers find that the Sigma2 Receptor can reduce neuropathic pain in animals when stimulated with a novel synthetic agonist (activating drug).
Researchers find that the Sigma2 Receptor can reduce neuropathic pain in animals when stimulated with a novel synthetic agonist (activating drug).
